NCT05530239View on ClinicalTrials.gov

Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

November 30, 2025

Conditions
Sickle Cell Disease
Interventions
OTHER

Blood sample collection

Blood sample collection

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT05530239 - Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects) | Biotech Hunter | Biotech Hunter